NCT07313254

Brief Summary

Periodontal intrabony defects pose a significant challenge in clinical dentistry due to their complex anatomy and limited regenerative potential. Recent advancements in biomaterials and regenerative techniques have introduced novel approaches to enhance periodontal healing. This study evaluates the clinical and radiographic outcomes of using nano-hydroxyapatite (nHA) and zinc-substituted nano-hydroxyapatite (Zn-nHA) in combination with advanced platelet-rich fibrin (A-PRF) blocks for the treatment of periodontal intrabony defects. Nano-hydroxyapatite, a biomimetic material, has shown promise in promoting bone regeneration due to its osteoconductive properties. Zinc substitution further enhances its biological activity by incorporating antimicrobial and osteoinductive characteristics. Advanced PRF, a second-generation platelet concentrate, provides a scaffold rich in growth factors and cytokines, which synergistically supports tissue regeneration.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 15, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2024

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 20, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 3, 2025

Completed
5 months until next milestone

First Posted

Study publicly available on registry

December 31, 2025

Completed
Last Updated

December 31, 2025

Status Verified

December 1, 2025

Enrollment Period

1 year

First QC Date

August 3, 2025

Last Update Submit

December 21, 2025

Conditions

Keywords

nano-hydroxyapatiteadvanced platelet-rich fibrin blockszinc-substituted nano-hydroxyapatite

Outcome Measures

Primary Outcomes (4)

  • measurement of gingival indices

    Gingival index (Loe et al.,1963): Score Criteria: 0- No inflammation. 1. Mild inflammation, slight change in color, slight edema, no bleeding on probing. 2. Moderate inflammation, moderate glazing, redness, bleeding on probing. 3. Severe inflammation, marked redness and hypertrophy, ulceration, tendency to spontaneous bleeding.

    From enrollment to the end of treatment at 6 months

  • measurement of plaque indices

    • Plaque index (Silness et al.,1964): We determine the amount of plaque on the tooth surface using a scale from 0 to 3: 0- No plaque 1. A film of plaque adhering to the free gingival margin and adjacent area of the tooth, which could not be seen with the naked eye. But only by using disclosing solutions or by using probe. 2. Moderate accumulation of deposits within the gingival pocket, on the gingival margin and/ or adjacent tooth surface, which could be seen with the naked eye. 3. Abundance of soft matter within the gingival pocket and/or on the tooth and gingival margin.

    6 monthes

  • measurement of probing pocket depth

    Probing pocket depth : Probing pocket depth (PD) is measured by using William's graduated probe from the free gingival margin to the base of the periodontal pocket.

    6 months

  • Measurement of Clinical attachment level

    The clinical attachment level (CAL) is measured by using periodontal probe from the cemento - enamel junction to the bottom of the pocket at each selected site.

    6 months

Study Arms (3)

treating with zinc substituted hydroxyapatite graft combined with PRF block using full flap

ACTIVE COMPARATOR

patients were treated with zinc substituted hydroxyapatite graft combined with platelet rich fibrin block using a full thickness mucoperiosteal flap surgical technique. After the pretreatment phase, patients were recalled under local anesthesia an intrasulcular incision was performed with #15 blade elevating a full-thickness mucoperiosteal flap and after removing all the inflammatory granulation tissue we put in the defect Zinc substituted nano-hydroxyapatite graft combined in platelet-rich fibrin block (A-PRF +I-PRF+graft ). Zinc substituted nano hydroxyapatite graft was taken in a bone well, to which i-PRF was mixed and the cut pieces of the A-PRF membrane were incorporated. The resulted cohesive, packable graft "PRF block" which were placed into the defect. Then the mucoperiosteal flap returned to its position in both groups and sutured using silk suture size (4/0).

Procedure: OFD with zinc substituted nano HA combined with PRF block

treating with zinc substituted nano-hydroxyapatite graft using a full thickness mucoperiosteal flap

ACTIVE COMPARATOR

patients were treated with zinc substituted nano-hydroxyapatite graft using a full thickness mucoperiosteal flap surgical technique.

Procedure: OFD with zinc substituted nano HA

treating with a nano-hydroxyapatite graft using full thickness mucoperiosteal flap surgical techniq

ACTIVE COMPARATOR

patients were treated with a nano-hydroxyapatite graft using a full thickness mucoperiosteal flap surgical technique.

Procedure: OFD with nano HA

Interventions

After the pretreatment phase, patients were recalled under local anesthesia an intrasulcular incision will performed with #15 blade elevating a full-thickness mucoperiosteal flap and after removing all the inflammatory granulation tissue we put in the defect Zinc substituted nano-hydroxyapatite graft combined in platelet-rich fibrin block (A-PRF +I-PRF+graft ). Zinc substituted nano hydroxyapatite graft was taken in a bone well, to which i-PRF was mixed and the cut pieces of the A-PRF membrane were incorporated. The resulted cohesive, packable graft "PRF block" which were placed into the defect. Then the mucoperiosteal flap returned to its position in both groups and sutured using silk suture size (4/0).

treating with zinc substituted hydroxyapatite graft combined with PRF block using full flap

After the pretreatment phase, patients were recalled under local anesthesia an intrasulcular incision will performed with #15 blade elevating a full-thickness mucoperiosteal flap and after removing all the inflammatory granulation tissue we put in the defect Zinc substituted nano-hydroxyapatite graft. Then the mucoperiosteal flap returned to its position in both groups and sutured using silk suture size (4/0).

treating with zinc substituted nano-hydroxyapatite graft using a full thickness mucoperiosteal flap

After the pretreatment phase, patients were recalled under local anesthesia an intrasulcular incision will performed with #15 blade elevating a full-thickness mucoperiosteal flap and after removing all the inflammatory granulation tissue we put in the defect nano-hydroxyapatite graft Then the mucoperiosteal flap returned to its position in both groups and sutured using silk suture size (4/0).

treating with a nano-hydroxyapatite graft using full thickness mucoperiosteal flap surgical techniq

Eligibility Criteria

Age20 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Adequate oral hygiene conditions.
  • Age range from 20 years to 50 years.
  • All patients will be physically healthy.
  • Patients who are co-operatively motivated.

You may not qualify if:

  • Those who smoke.
  • Women who are pregnant.
  • Patients with poorly controlled systemic diseases which preclude local anesthesia or surgical procedures.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Eman Yehia

Ismailia, Ismailia Governorate, 54321, Egypt

Location

Related Publications (1)

  • Bhardwaj VA, Deepika PC, Basavarajaiah S. Zinc Incorporated Nano Hydroxyapatite: A Novel Bone Graft Used for Regeneration of Intrabony Defects. Contemp Clin Dent. 2018 Jul-Sep;9(3):427-433. doi: 10.4103/ccd.ccd_192_18.

Related Links

MeSH Terms

Conditions

PeriodontitisPeriodontal Diseases

Condition Hierarchy (Ancestors)

Mouth DiseasesStomatognathic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Masking Description
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Model Description
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 3, 2025

First Posted

December 31, 2025

Study Start

January 15, 2023

Primary Completion

January 15, 2024

Study Completion

May 20, 2025

Last Updated

December 31, 2025

Record last verified: 2025-12

Locations